je.st
news
Tag: initiation
Whirlpool (WHR) Stock May Rally on Analyst Initiation
2015-05-08 15:13:04| Appliances - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: stock
analyst
rally
initiation
Advaxis and Merck Announce Initiation of Enrollment in the Phase 1/2 Study of ADXS-PSA in Combination with Anti-PD-1 Therapy, KEYTRUDA (pembrolizumab), for the Treatment of Advanced Prostate Cancer
2015-04-08 13:30:05| Merck.com - Product News
Dateline City: PRINCETON, N.J., and KENILWORTH, N.J. KEYNOTE-046 is the second trial initiated to evaluate KEYTRUDA, and the first-in-human study of ADXS-PSA, for prostate cancer Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced that enrollment has initiated in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA (ADXS31-142), an investigational Lm-LLO immunotherapy, and KEYTRUDA (pembrolizumab), the first anti-PD-1 (programmed death receptor-1) therapy approved in the United States, in patients with previously treated, metastatic castration-resistant prostate cancer (mCRPC). Language: English read more
GEOS Carries out Several Tests Using Initiation Systems
2015-03-02 15:37:00| Naval Technology
The Special Operations Group (GEO), the Spanish Elite Police Unit, has trialled EXPAL's latest developments in demolition charges and initiation systems at its facilities in Guadalajara.
Tags: systems
tests
carries
initiation
BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430...
2014-12-15 18:43:01| Biotech - Topix.net
BioCryst Pharmaceuticals, Inc. today announced the dosing of the first subject in a randomized, placebo-controlled Phase 1 clinical trial to evaluate intramuscular administration of BCX4430 in healthy volunteers. BCX4430 is being developed as a potential treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease.
Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA
2014-11-25 16:58:52| Biotech - Topix.net
Isis Pharmaceuticals, Inc. announced today the initiation of a pivotal Phase 3 study evaluating ISIS-SMNRx in approximately 120 non-ambulatory children with spinal muscular atrophy . SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness.
Tags: with
study
children
phase